2020 American Transplant Congress Archives - Page 195 of 223

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

Saturday, May 30, 2020

3:51pm-4:03pm: TIM-4+ Kupffer Cells Play Homeostatic Roles in Liver Ischemia Reperfusion Injury

M. Ni¹, J. Zhang¹, R. Sosa², S. Kageyama¹, R. Busuttil¹, R. Elaine², J. Kupiec-Weglinski¹, X. Wang³, Y. Zhai¹

Basic: Ischemia Reperfusion & Organ Rehabilitation II • Virtual

3:51pm-4:03pm: Time for Change: Assessment of Renal Transplant Artery Stenosis with N.A.T.I.V.E. True-F.I.S.P. and N.A.T.I.V.E. G.R.E

J. C. Infante¹, A. Mattiazzi², M. Morsi³, G. Guerra², M. J. Defreitas⁴, J. Chandar⁴, L. J. Chen³, G. W. Burke³, J. Figueiro³, G. Ciancio³

Kidney: Cardiovascular and Metabolic Complications II • Virtual

3:51pm-4:03pm: Timing of Bariatric Surgery for Obese Liver Transplant Candidates

R. A. Choudhury¹, D. Yoeli², G. Hoeltzel³, H. B. Moore², H. Yaffe², K. R. Dumon⁴, N. N. Williams⁴, P. L. Abt⁵, K. D. Conzen², J. J. Pomposelli², E. A. Pomfret², T. L. Nydam²

Surgical Issues • Virtual

3:51pm-4:03pm: Total Penis, Scrotum, and Lower Abdominal Wall Transplant: 18-Month Update

D. S. Cooney¹, C. M. Cooney¹, V. Javia¹, J. T. Shores¹, A. L. Burnett², T. J. Bivalacqua², G. Brandacher¹, R. J. Redett¹

Vascularized Composite Allograft • Virtual

3:51pm-4:03pm: Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease after Kidney Transplantation

M. Raynaud¹, O. Aubert¹, P. Reese², M. Naesens³, D. Glotz¹, C. Legendre¹, S. Jordan⁴, M. Stegall⁵, D. Segev⁶, C. Lefaucheur¹, A. Loupy, On behalf of the study NCT03474003¹

Biomarkers, Immune Assessment and Clinical Outcomes I • Virtual

3:51pm-4:03pm: Uromodulin to Osteopontin Ratio in Deceased Donor Urine is Associated with Kidney Graft Outcomes

S. G. Mansour¹, C. Liu², Y. Jia², P. Reese³, I. Hall⁴, T. El-Achkar⁵, K. LaFavers⁵, W. Obeid², M. Thangamani⁶, A. Rosenberg², M. Doshi⁷, E. Akalin⁸, J. Bromberg⁹, M. Harhay¹⁰, S. Mohan¹¹, B. Schröppel¹², P. Daneshpajouhnejad², P. Singh¹³, F. Weng¹⁴, H. Thiessen-Philbrook², C. Parikh²

Biomarkers, Immune Assessment and Clinical Outcomes II • Virtual

3:51pm-4:03pm: Utilization of Kidneys from Deceased Donors with Positive Hepatitis C Nucleic Acid Amplification Testing (HCV NAT+)

K. L. King, S. A. Husain, S. Mohan

Kidney Deceased Donor Selection I • Virtual

3:51pm-4:03pm: What Are the Peri-Operative and Longterm Outcomes of Utilizing Donation after Circulatory Death Livers with Macrosteatosis? A Multicenter Analysis

K. Croome¹, A. Mathur², S. Mao¹, B. Aqel³, P. Senada¹, J. Piatt¹, J. Heimbach⁴, A. Moss³, C. Rosen⁴, C. Taner¹

Liver: MELD, Allocation and Donor Issues (DCD/ECD) I • Virtual

4:03pm-4:15pm: A Data-Driven Approach to Defining the Volume-Outcome Relationship in Liver Transplantation

M. D. Bailey, E. L. Godfrey, W. C. Frankel, A. Rana

Biomarkers, Immune Assessment and Clinical Outcomes IV • Virtual

4:03pm-4:15pm: A Multidisciplinary Protocol for the Management of Hyponatremia at the Time of Liver Transplantation is Associated with Reduced Post-Transplant Neurologic Complications

J. F. Crismale, T. Huisman, R. Deshpande, C. Law, G. Im, D. Bronster, S. Demaria Jr, S. Florman, T. Schiano

Liver Retransplantation and Other Complications • Virtual